Narrative review / 2018
A review indicates intermittent fasting activates lysosomal autophagy and metabolic programs that may protect against cardiometabolic disease.
This review synthesizes insights from animal and human studies evaluating adaptive physiological responses to starvation, intermittent fasting, and chronic caloric restriction. These dietary strategies are reported to extend lifespan, lower risk factors for cardiometabolic and inflammatory disease, decrease tissue injury during myocardial stress, and activate a cardioprotective metabolic program. Furthermore, acute fasting induces autophagy—a lysosomal degradative process essential for cardiac homeostasis—with lysosomes serving as central regulators of cellular metabolism and nutrient sensing.
- Study type
- Narrative review
- Who was studied
- Animal and human studies
- What was measured
- Effects of intermittent fasting on cardiometabolic disease, autophagy, and lysosomal function
THE PAPER
Lysosomes Mediate Benefits of Intermittent Fasting in Cardiometabolic Disease: The Janitor Is the Undercover Boss.
Mani K, Javaheri A, Diwan A. Compr Physiol, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.